1. Potential therapeutic targets for trauma management.
- Author
-
Li, Zizheng, Qiao, Ou, Wang, Yuru, Li, Ning, and Gong, Yanhua
- Subjects
- *
DRUG target , *VACCINE development , *THERAPEUTICS , *COMMUNICABLE diseases , *NON-communicable diseases , *SEPSIS - Abstract
Damage-associated molecular patterns (DAMPs) released in large quantities in trauma are important triggers of post-traumatic immune dysfunction and interest in their potential as therapeutic targets for trauma has increased. Targeting DAMPs such as myoglobin, HMGB1, histones, and nucleic acids have potential for the development of vaccines for trauma. Due to the specific nature of trauma, significant challenges such as the possibility of trauma vaccines causing autoimmune diseases requires further research. The development of trauma vaccines has the potential to establish protection for populations at high risk for trauma and may supplement existing trauma management strategies. Despite advances in medical treatments for severe trauma, it remains a critical condition associated with high mortality. During trauma, the release of endogenous damage-associated molecular patterns (DAMPs) can induce immune dysfunction, leading to sepsis or multiple organ dysfunction syndrome (MODS). Vaccines based on specific pathogen antigens and pathogen-associated molecular patterns (PAMPs) contribute largely to the prevention of communicable diseases through the induction of adaptive immune responses. Vaccines developed based on autologous molecules may also promote recovery from non-communicable diseases (NCDs) by eliciting appropriate immune responses, as recent clinical trials indicate. Developing new vaccines targeting DAMPs may be an effective pre-protective measure for trauma management. We describe the role of DAMPs in post-traumatic immune dysfunction and discuss the potential of harnessing them for trauma vaccine development as well as the risks and challenges. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF